Code Climate Adds Former VMware and Return Path Leaders to
Code Climate adds Anita Absey and Josh Knowles to their executive team to scale sales and operations of its
Globe Newswire7-03-2023, 21:06
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26